摘要
目的研究分析辛伐他汀联合低分子肝素钠治疗冠心病心绞痛的临床效果。方法将156例患者按照数字随机法均分为对照组和观察组,每组各78例。对照组患者给予抗心绞痛药物进行常规治疗,观察组患者在对照组的基础上给予辛伐他汀联合低分子肝素钠进行治疗,比较两组治疗效果。结果观察组治疗总有效率高于对照组的高,差异具有统计学意义(P<0.05)。结论辛伐他汀联合低分子肝素钠治疗冠心病心绞痛疗效更加确切,而且安全性高,有效改善患者的病情,提高生活质量。
Objective To study the effect of simvastatin combined with low molecular heparin for treatment of coronary heart disease angina pectoris. Methods Using digital random method to divided 156 cases into control group and observation group,78 cases in each group. Control group patients were given anti angina pectoris drugs for regular treatment,observation group patients were given simvastatin combined with low molecular heparin,compared two groups of therapeutic effect. Results In observation group,total effective rate was significantly higher than control group,the difference was statistically significant（P〈0.05）. Conclusion Simvastatin combined with low molecular heparin sodium have exact curative effect on coronary heart disease angina pectoris.
出处
《中国卫生标准管理》
2015年第16期91-92,共2页
China Health Standard Management
